-
Mashup Score: 1Advancing Oncology at the Speed of Life | Amgen Oncology - 1 year(s) ago
At Amgen we are committed to changing the course of cancer treatment for more than 40 years. Learn about all of the different Amgen Oncology web propoerties and resources that Amgen has to offer.
Source: www.amgenoncology.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4HEAL Collaborative: Health Education Advocacy Learning - 1 year(s) ago
HEAL Collaborative is a community-based organization with a mission to make communities of color healthier through healthcare education and advocacy.
Source: healcollaborative.orgCategories: General Medicine News, PayerTweet-
Fact: Black Americans with #lungcancer experience poorer outcomes than their white counterparts. @HEALCollab works to eliminate healthcare disparities by communicating accurate info to empower people to get the care they deserve: https://t.co/PNMaNxjmSR #MinorityHealthMonth https://t.co/iRTAK3vWBX
-
-
Mashup Score: 1Home - 1 year(s) ago
Biomarkers are the key to treating stomach cancer. Test first. Because the best treatment for your stomach cancer can be individualized.
Source: testyourbiomarkers.orgCategories: General Medicine News, PayerTweet-
Knowing your cancer’s specific #biomarkers helps you and your healthcare team identify treatment options – now and in the future. Learn about the role of biomarkers in gastric cancer treatment planning 🔗 https://t.co/czzRfD7cGD #AmgenSponsored https://t.co/0OkpWaLSxt
-
-
Mashup Score: 3Home - 1 year(s) ago
Learn how DLL3 and T-cell engager technology together have the potential to address unmet needs in SCLC and high-grade neuroendocrine cancers.
Source: www.dll3possibilities.comCategories: General Medicine News, PayerTweet-
At @Amgen, we harness the power of science to take on cancer’s toughest challenges. In small cell lung cancer (#SCLC), we’re working to bring patients’ own T cells to the fight. Learn about our investigational immunotherapy at https://t.co/EQEdZ7g3cs https://t.co/cx990836Jw
-
-
Mashup Score: 15Jean-Charles Soria Elected to AACR Board of Directors - 1 year(s) ago
Jean-Charles Soria, Amgen’s senior vice president of Oncology within Global Development, has been elected to the American Association for Cancer Research (AACR) Board of Directors for the 2024-2027 term.
Source: wwwext.amgen.comCategories: General Medicine News, PayerTweet-
Congratulations to Amgen’s @jsoriamd on his election to the @AACR Board of Directors! 👏 Jean-Charles will lend his expertise in precision medicine and immuno-oncology to help guide Association policy and advance cancer research. Click to learn more 🔗 https://t.co/MTIh0VqFEm https://t.co/3huuXQrbed
-
-
Mashup Score: 0
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Source: www.curetoday.comCategories: General Medicine News, PayerTweet-
“Without the biomarker testing, the targeted treatment wouldn’t have been a possibility.” Gina shares her experience living with metastatic colorectal cancer in this #AmgenSponsored @cure_today article: https://t.co/HVrQrWtSo5 #ColorectalCancerAwarenessMonth https://t.co/tTgoTpGi1b
-
-
Mashup Score: 6Call-on Congress | Fight Colorectal Cancer - 1 year(s) ago
We demand that policymakers act. We can’t afford to wait, lives are at stake today! Join us in D.C — we need to fight for more.
Source: fightcolorectalcancer.orgCategories: General Medicine News, PayerTweet-
.@FightCRC has united members of the #ColorectalCancer community in Washington, D.C. to advocate for meaningful policy change. 👏🏽👏🏽👏🏽 Show your support: https://t.co/C2nezrD5ul https://t.co/WqZPhTvO7W
-
-
Mashup Score: 6Call-on Congress | Fight Colorectal Cancer - 1 year(s) ago
We demand that policymakers act. We can’t afford to wait, lives are at stake today! Join us in D.C — we need to fight for more.
Source: fightcolorectalcancer.orgCategories: General Medicine News, PayerTweet-
.@FightCRC has united members of the #ColorectalCancer community in Washington, D.C. to advocate for meaningful policy change. 👏🏽👏🏽👏🏽 Show your support: https://t.co/C2nezrD5ul https://t.co/WqZPhTvO7W
-
-
Mashup Score: 5Home - 1 year(s) ago
Learn how DLL3 and T-cell engager technology together have the potential to address unmet needs in SCLC and high-grade neuroendocrine cancers.
Source: www.dll3possibilities.comCategories: General Medicine News, PayerTweet-
🧬 Scientific advances help bring the light of hope to the darkness of cancer. Discover the powerful #research for small cell lung cancer 🔗 https://t.co/MOvUONemka #SCLC https://t.co/DIrvpqIjlc
-
-
Mashup Score: 2Home - 1 year(s) ago
Biomarkers are the key to treating stomach cancer. Test first. Because the best treatment for your stomach cancer can be individualized.
Source: testyourbiomarkers.orgCategories: General Medicine News, PayerTweet-
For people with gastric cancer, biomarker testing can play an important role in treatment planning. Discover how biomarkers can help determine strategies for optimal care with @Amgen-supported resources from @testbiomarkers: https://t.co/DHNn9H1f8i https://t.co/ObYAFFVuvB
-
Cancer is deeply personal, and cancer care should be, too. Through our science and understanding of the unique biology underlying each person and each cancer, we aim to expand treatment possibilities. đź”— Discover how: https://t.co/lcWji3vAUL https://t.co/Q9Ttxcazsw